Welcome to the Largest Biopharma Forum for All Radiopharmaceutical Stakeholders
The targeted radiopharmaceutical field is undergoing significant expansion, with progressing clinical candidates and growing novel pipelines. Precision radiopharmaceuticals represent a golden opportunity to shape the future of medicine.
As demand for radiopharmaceuticals increases, the field is working to strengthen isotope supply, enhance patient access and bring more therapeutic candidates to the clinic. Bringing together the industry leaders that are making it all happen, the 4th Targeted Radiopharmaceuticals Summit US returns to San Diego as the largest end-to-end, industry focused platform. Gathering 275+ global stakeholders, sharing exclusive scientific and strategic insights from players including Novartis, AstraZeneca, BMS, Ratio Therapeutics, Alpha-9 Oncology, AdvanCell, Mariana Oncology, Abdera Therapeutics and many more!
Discover novel engineering for cutting-edge targeting molecules, increase successful clinical translation and gain clarity on isotope supply in our three dedicated tracks of content Discovery & Preclinical, Translational & Early Stage Clinical and Supply Chain & Late Stage Clinical.
Attending Companies Include







